Literature DB >> 19549194

'Natalizumab in paediatric multiple sclerosis and service implication'.

Richard E Appleton, Mike Boggild.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19549194     DOI： 10.1111/j.1469-8749.2009.03378.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  3 in total

1.  Therapeutic strategies in childhood multiple sclerosis.

Authors:  Angelo Ghezzi
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

2.  Best practice in the use of natalizumab in multiple sclerosis.

Authors:  Oscar Fernández
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

3.  Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Authors:  Angelo Ghezzi; Giancarlo Comi; Luigi Maria Grimaldi; Lucia Moiola; Carlo Pozzilli; Simone Fantaccini; Paolo Gallo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.